<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Summary of key parameter estimates from fitting within-host and between-host models to data.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Parameter</th>
    <th>Median</th>
    <th>95% CI lower</th>
    <th>95% CI upper</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Antiviral efficacy 
     <inline-formula id="IEq1">
      <alternatives>
       <tex-math id="M1">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\epsilon$$\end{document}</tex-math>
       <math id="M2">
        <mi>ϵ</mi>
       </math>
       <inline-graphic xlink:href="41467_2020_16585_Article_IEq1.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
      </alternatives>
     </inline-formula> for baloxavir
    </td>
    <td>0.9997</td>
    <td>0.9996</td>
    <td>0.9999</td>
   </tr>
   <tr>
    <td>Antiviral efficacy 
     <inline-formula id="IEq2">
      <alternatives>
       <tex-math id="M3">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\epsilon$$\end{document}</tex-math>
       <math id="M4">
        <mi>ϵ</mi>
       </math>
       <inline-graphic xlink:href="41467_2020_16585_Article_IEq2.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
      </alternatives>
     </inline-formula> for oseltamivir
    </td>
    <td>0.89</td>
    <td>0.88</td>
    <td>0.90</td>
   </tr>
   <tr>
    <td>Initial sensitive viral load 
     <italic>V</italic>
     <sub>
      <italic>0</italic>
     </sub> (TCID
     <sub>50</sub>/ml)
    </td>
    <td>258.2</td>
    <td>3.3
     <sup>a</sup>
    </td>
    <td>2268.9
     <sup>a</sup>
    </td>
   </tr>
   <tr>
    <td>Basic reproduction number 
     <italic>R</italic>
     <sub>0</sub> in 2016–2017 season
    </td>
    <td>1.09</td>
    <td>1.06</td>
    <td>1.11</td>
   </tr>
   <tr>
    <td>Basic reproduction number 
     <italic>R</italic>
     <sub>0</sub> in 2017–2018 season
    </td>
    <td>1.15</td>
    <td>1.12</td>
    <td>1.17</td>
   </tr>
   <tr>
    <td>Basic reproduction number 
     <italic>R</italic>
     <sub>0</sub> in 2018–2019 season
    </td>
    <td>1.10</td>
    <td>1.08</td>
    <td>1.13</td>
   </tr>
   <tr>
    <td>Baseline distribution of treatment initiation time, 
     <italic>G</italic>
     <sub>0–48</sub> (hours after symptom onset, truncated at 48 h)
    </td>
    <td colspan="3">
     <italic>G</italic>(4.0, 6.3)
    </td>
   </tr>
   <tr>
    <td>Accelerated distribution of treatment initiation times, 
     <italic>G</italic>
     <sub>0–24</sub> (hours after symptom onset, truncated at 24 h)
    </td>
    <td colspan="3">
     <italic>G</italic>(4.0, 6.3)/2
    </td>
   </tr>
   <tr>
    <td>Delayed distribution of treatment initiation times, 
     <italic>G</italic>
     <sub>24–48</sub> (hours after symptom onset, compressed to 24–48 h window)
    </td>
    <td colspan="3">
     <italic>G</italic>(4.0, 6.3)/2 + 24
    </td>
   </tr>
   <tr>
    <td>Distribution of time lag between infection and symptom onset, 
     <italic>L</italic> (hours)
    </td>
    <td colspan="3">24
     <sup>a</sup>
     <italic>L</italic>(0.37,0.41)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup>For estimates derived by simulated annealing, we provide 95 percentile range rather than confidence intervals.
  </p>
  <p>Viral replication and antiviral efficacy are estimated via simulated annealing
   <sup>
    <xref ref-type="bibr" rid="CR46">46</xref>
   </sup> and approximate Bayesian computation
   <sup>
    <xref ref-type="bibr" rid="CR38">38</xref>,
    <xref ref-type="bibr" rid="CR39">39</xref>,
    <xref ref-type="bibr" rid="CR47">47</xref>
   </sup> fitting of deterministic within-host model to clinical trial data;
   <sup>
    <xref ref-type="bibr" rid="CR8">8</xref>
   </sup> season-specific transmission rates are estimated via approximate Bayesian computation
   <sup>
    <xref ref-type="bibr" rid="CR38">38</xref>,
    <xref ref-type="bibr" rid="CR39">39</xref>
   </sup> fitting of stochastic population-level influenza transmission model (Supplementary Section 
   <xref rid="MOESM1" ref-type="media">1</xref>) to US seasonal influenza incidence data
   <sup>
    <xref ref-type="bibr" rid="CR12">12</xref>
   </sup>. Parameters for distributions of time between infection and symptom onset (lognormal) and from symptom onset to treatment (gamma) were estimated by the interior-point algorithm fitting of clinical trial data
   <sup>
    <xref ref-type="bibr" rid="CR8">8</xref>
   </sup>. The key parameter estimates of within-host model and between-host model are summarized here, whereas others are in Supplementary Tables 
   <xref rid="MOESM1" ref-type="media">2</xref> and 
   <xref rid="MOESM1" ref-type="media">3</xref>.
  </p>
 </table-wrap-foot>
</table-wrap>
